Market Overview:
Global Drug Delivery Systems Market Size Was Valued at USD 39.55 Billion In 2022 And Is Projected to Reach USD 78.76 Billion By 2030, Growing at A CAGR of 9.1% From 2023 To 2030.
The process of administering a pharmaceutical compound to achieve a therapeutic effect in humans or animals is known as drug delivery. The first generation (1950–1980) produced a large number of oral and transdermal controlled-release formulations for clinical applications. In the recent research and development (R & D) sector, scientific and technical developments are ready for the expansion of oral drug delivery systems. Because of the benefits of ease of administration, improved patient compliance, and convenience, the oral route is one of the most widely used routes of drug administration. In immediate release (IR) dosage forms, there is little or no control over the release of drug from the dosage form, which frequently results in constantly changing, unpredictable, and frequently sub- or supra-therapeutic plasma concentrations.
Top Key Players in Drug Delivery Systems Market:
Gerresheimer AG(Germany), BD (Becton, Dickinson, and Company) (U.S), Kindeva Drug Delivery (U.S.), Baxter (U.S.), West Pharmaceutical Services Inc. (U.S.), Ypsomed (Switzerland), Medtronic (Ireland), Nemara (France), E3D Elcam Drug Delivery Devices (Israel), Pfizer Inc. (U.S), 3M (U.S), and Other Major Players.
Market Dynamics and Factors for Drug Delivery Systems Market:
Drivers:
A Rise in The Prevalence of Chronic Diseases
Chronic diseases increase in the world due to, the rising aging population, as well as changes in societal behavior, which are all contributing to a steady rise in these common and costly long-term health issues. People are becoming more sedentary as the middle class expands and urbanization accelerates leading to an increase in the use of tobacco and exposure to secondhand smoke. Poor nutrition, including diets low in fruits and vegetables and high in sodium and saturated fats. Physical Inactivity. It tends to rise the cases of chronic diseases. Obesity rates and cases of diseases such as diabetes are rising as a result. According to the World Health Organization, the prevalence of chronic diseases was 57% in 2020. Emerging markets will be hardest hit, as population growth is expected to be greatest in developing countries.
Opportunities:
Lucrative Opportunity in the Growing Production of Novel Drugs
The drug delivery system market is expected to healthy growth in the coming years, owing to the advances in the drug delivery system gaining attention and popularity as a result of the use of Nano formulations, which enable efficient, effective, and specific drug targeting. Liposomes, aptamers, quantum dots, peptides, polymers, metals, and magnetic nanoparticle-based delivery are examples of advanced-generation drug delivery systems. The structural complexity of Nano-based drug delivery systems, such as dendrimers, Nano sponges, nanocrystals, nanogels, and Nanocapsules, provides a large surface area for precise targeting in cancer management and other life-threatening diseases.
Segmentation Analysis of the Drug Delivery Systems Market:
By Type, the oral drug delivery segment is forecasted to dominate the drug delivery system market in the upcoming future. The Oral drug delivery system is commonly used for the administration of the drug. It is the most preferred route and most well-known route of drug administration because it is easy to use, non-invasive in nature, cost-effective, and has high absorption properties in the gastrointestinal tract.
By Applications, cardiovascular diseases are anticipated to lead the drug delivery system market in the projected timeframe Cardiovascular disease dominates the market of drug delivery systems. In the world, 520 million people are affected by cardiovascular diseases.
Regional Analysis of the Drug Delivery Systems Market:
North America is anticipated to have the highest share of the drug delivery system market in the forecast period due to the increased adoption rate of new technological advancements in the drug delivery system. The United States is a prominent country in the North American region. During the forecast period, the US drug delivery systems market is expected to grow at the fastest rate. The increasing prevalence of chronic diseases and the growing number of products launched by key players, and the increasing use of drug delivery systems for disease management are driving the growth of this market. Strong demand for drug delivery systems is expected to drive the drug delivery systems market growth in North America during the forecast period, owing to an increase in hospital admissions in the region.
Key Industry Development:
In December 2021, Gerresheimer AG signed a significant agreement with American Biotech to develop a new pump to deliver a drug for the treatment of rare diseases via continuous parenteral administration.
In November 2020, Medtronic will release the InPen with real-time Guardian Connect CGM data in November 2020. The product displays real-time glucose levels as well as insulin dose information.
Regional Outlook (Revenue in USD Million; Volume in Units, 2023-2030)
North America
- US
- Canada
- Mexico
Eastern Europe
- Bulgaria
- The Czech Republic
- Hungary
- Poland
- Romania
- Rest of Eastern Europe
Western Europe
- Germany
- UK
- France
- Netherlands
- Italy
- Russia
- Spain
- Rest of Western Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Malaysia
- Thailand
- Vietnam
- The Philippines
- Australia
- New Zealand
- Rest of APAC
Middle East & Africa
- Turkey
- Bahrain
- Kuwait
- Saudi Arabia
- Qatar
- UAE
- Israel
- South Africa
South America
- Brazil
- Argentina
- Rest of SA
